Jubilant Strengthens its Business Model in North America - Strategically Aligns HollisterStier and DRAXIS- Announces New Leadership

    NOIDA, UP, India, Oct. 29 /CNW Telbec/ - Jubilant Organosys Ltd.,
announced today that it has strategically aligned its two newly acquired
entities, HollisterStier Laboratories LLC and DRAXIS Specialty Pharmaceuticals
Inc. ("DRAXIS"), operating in USA and Canada respectively, in order to
leverage the strengths of these entities in the area of contract manufacturing
of sterile injectables & non sterile products and specialty pharmaceuticals.
    This strategic move will result in cohesive operations, focus on research
& development and product innovation in the areas of Specialty
Pharmaceuticals, and will consolidate Jubilant's leadership in the areas of
both sterile and non-sterile Contract Manufacturing by leveraging multi-site
    To spearhead these specialized businesses, Jubilant has carved new
leadership roles for Chief Executives. Accordingly, Mr. Jean Pierre Robert has
been appointed as the Chief Executive Officer for the Specialty Pharmaceutical
organization. In his new role, he will be responsible for the
radiopharmaceuticals business of DRAXIS as well as the Allergy Extracts
business of Hollister-Stier Laboratories.
    Mr. Marcelo Morales has been appointed as the Chief Executive Officer for
Contract Manufacturing, and will have responsibility of the sterile
injectables manufacturing arm of HollisterStier and the sterile injectable,
semi- solids and solid dose manufacturing operations of DRAXIS.
    "This strategic realignment will enable us to drive value for our
customers through synergistic operations and will offer exciting opportunities
for all of us," said Jubilant Organosys Chairman and Co-Chairman, Shyam and
Hari Bhartia. "With a focus on continuous innovation, expansion of service
offerings and locations we ensure that our customers receive the desired level
of quality, flexibility and expertise to meet the market demands." they added

    About Jubilant

    Jubilant Organosys Ltd. is an integrated pharmaceutical industry player,
one of the largest custom research and manufacturing services (CRAMS) and drug
discovery and development services companies out of India. The company has a
presence across the pharmaceutical value chain for products and services such
as proprietary products, exclusive synthesis, active pharmaceutical
ingredients, contract manufacturing of sterile injectables (liquids and
lyophilized) products, non-steriles (ointments, creams and liquid) and
radiopharmaceuticals, drug discovery services, medicinal chemistry services,
clinical research services ,generic dosage forms and Health Care.
    Jubilant Organosys has geographically diversified manufacturing
facilities at ten locations: Gajraula (UP), Nanjangud (Karnataka), Roorkee
(Uttarakhand), Nira (Maharashtra), Udaipur (Rajasthan), Samlaya (Gujarat),
Ambarnath (Mumbai) Salisbury, state of Maryland (USA), Spokane, state of
Washington (USA) and Kirkland, Province of Quebec (Canada). Together, these
help Jubilant cater to 150 customers across more than 50 countries around the
    For more information: visit www.jubl.com

    About DRAXIS

    DRAXIS Specialty Pharmaceuticals Inc., provides products in three
categories: sterile products, non-sterile products and radiopharmaceuticals.
Sterile products include liquid and freeze-dried (lyophilized) injectables
plus sterile ointments and creams. Non-sterile products are produced as solid
oral and semi-solid dosage forms. Radiopharmaceuticals are used for both
therapeutic and diagnostic molecular imaging applications. Pharmaceutical
contract manufacturing services are provided through DRAXIS Pharma General
Partnership and radiopharmaceuticals are developed, produced, and sold through
the DRAXIMAGE division. DRAXIS employs approximately 500 staff in its Kirkland
(Québec) facility.
    For more information about DRAXIS visit www.draxis.com.

    About HollisterStier

    HollisterStier Laboratories LLC, a company located in Spokane, WA, USA,
is a leading contract manufacturer of Sterile Injectable, vials &
Lyophilization products and one of the world top producers of Allergenic
extracts. The Company has distinct cGMP areas in Small Volume Parenterals
including Commercial small volume Parenterals, Small Lot Manufacturing and
Clinical Trial manufacturing facilities. The company has global branded,
generic pharmaceutical and biotechnology companies as its customers.
    For further information about HollisterStier Laboratories, visit

    Statements in this document relating to future status, events, or
circumstances, including but not limited to statements about plans and
objectives, the progress and results of research and development, potential
product characteristics and uses, product sales potential and target dates for
product launch are forward-looking statements based on estimates and the
anticipated effects of future events on current and developing circumstances.
Such statements are subject to numerous risks and uncertainties and are not
necessarily predictive of future results. Actual results may differ materially
from those anticipated in the forward-looking statements. Jubilant Organosys
may, from time to time, make additional written and oral forward-looking
statements, including statements contained in the company's filings with the
regulatory bodies and our reports to shareholders. The company assumes no
obligation to update forward-looking statements to reflect actual results,
changed assumptions or other factors.

For further information:

For further information: India: For Media: Seema Ahuja, Jubilant
Organosys Limited, +91-120-4361062, Mobile - +91-9810631779,
seema_ahuja@jubl.com; For Investors: Deepak Malik, Jubilant Organosys Limited,
+91-120 4361114, Fax: +91-120- 2516629, deepak_malik@jubl.com; Siddharth
Rangnekar, Citigate Dewe Rogerson, +91 -22 4007 5005, Fax: +91-22- 2284 4561,
siddharth@cdr-india.com; Canada: Alida Gualtieri, DRAXIS Specialty
Pharmaceuticals Inc., (514) 630-7061, Fax: (514) 630-7159,
agualtieri@draxis.com; U.S.A.: Kirk Wood-Gaines, HolisterStier Laboratories
LLC, (509) 489-5656 x4442, Fax: (509) 482-1792,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890